Synorga Pharmaceuticals Ltd - Company Profile

It is a trading public limited company based in Delhi, Delhi, India, established in 1981.
1981 Delhi, Delhi, India Active
Last Updated:
About Synorga Pharmaceuticals Ltd

Synorga Pharmaceuticals Ltd, a active public limited company, was established on 01 July 1981 in Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U24230DL1981PLC011952. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Manmohan Singh Phull (Director), Surinder Singh (Director), Kultaran Singh Kochhar (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 14/ 2, Ashok Nagar, New Delhi, Delhi, Delhi, 110018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230DL1981PLC011952

  • Registration Number

    011952

  • Incorporation Date

    01 July 1981

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 44 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Synorga Pharmaceuticals Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Synorga Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synorga Pharmaceuticals Ltd?
Current Directors
Name Designation Appointment Date Status
Manmohan Singh Phull Director 30 Jan 2001 Current
Surinder Singh Director 30 Jan 2001 Current
Kultaran Singh Kochhar Director 01 Sep 1987 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synorga Pharmaceuticals.

Synorga Pharmaceuticals Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Synorga Pharmaceuticals revenue growth over time
Synorga Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synorga Pharmaceuticals?

In 2017, Synorga Pharmaceuticals had a promoter holding of 6.20% and a public holding of 93.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synorga Pharmaceuticals?

Unlock and access historical data on people associated with Synorga Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synorga Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synorga Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synorga Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Synorga Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Synorga Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was completed.

  • Director Appointment

    Progress on Manmohan Singh Phull was appointed as a Director was appointed as a Director on 30 Jan 2001 & has been associated with this company since 25 years 1 month . was documented.

  • Director Appointment

    The activity Surinder Singh was appointed as a Director was appointed as a Director on 30 Jan 2001 & has been associated with this company since 25 years 1 month . was completed.

  • Director Appointment

    Progress on Kultaran Singh Kochhar was appointed as a Director was appointed as a Director on 01 Sep 1987 & has been associated with this company since 38 years 6 months . was documented.

  • Company Incorporation

    Progress on Synorga Pharmaceuticals Ltd was registered on 01 Jul 1981 with Roc Delhi Ii & aged 44 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synorga Pharmaceuticals Ltd?

The CIN of Synorga Pharmaceuticals Ltd is U24230DL1981PLC011952.

Where is Synorga Pharmaceuticals Ltd headquartered?

Synorga Pharmaceuticals Ltd is headquartered at 14/ 2, Ashok Nagar, New Delhi, Delhi, Delhi, 110018.

When was Synorga Pharmaceuticals Ltd incorporated?

Synorga Pharmaceuticals Ltd was incorporated on 01 July 1981.

Who are the current directors of Synorga Pharmaceuticals Ltd?

The current directors of Synorga Pharmaceuticals Ltd are

What is the primary industry of Synorga Pharmaceuticals Ltd?

The primary industry of Synorga Pharmaceuticals Ltd is Trade.

Is Synorga Pharmaceuticals Ltd a listed company?

Synorga Pharmaceuticals Ltd is unlisted.

What is the capital structure of Synorga Pharmaceuticals Ltd?

The authorized capital of Synorga Pharmaceuticals Ltd is ₹5.00 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Synorga Pharmaceuticals Ltd?

The compliance status of Synorga Pharmaceuticals Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available